Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PIK3CA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
PIK3CA is a gene implicated in neurodegeneration research. Key relationships include: therapeutic target, associated with, interacts with. Associated with Aging, Als, Amyotrophic Lateral Sclerosis. Connected to 338 entities in the SciDEX knowledge graph.
| Gene Symbol | PIK3CA |
| Chromosome | 3q26.32 |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Molecular Weight | 120 kDa |
| Amino Acids | 068 aa |
| Exons | 21 |
| Pathways | PI3K, mTOR |
| GeneCards | PIK3CA |
| Human Protein Atlas | PIK3CA |
| PIP2 | PIP3 |
| PI(4)P | PI(3,4)P2 |
| PI | PI(3)P |
| Approach | Agent |
| PI3K inhibitors | Wortmannin, LY294002 |
| Akt inhibitors | Akti-1/2 |
| Associated Diseases | ALS, Aging, BREAST CANCER |
| Known Drugs/Compounds | Chrysotoxine, Apitolisib, Paxalisib, Alpelisib, rapamycin |
| Interactions | PTEN, AKT, PI3K, MMP9, PPARA, IGF1R |
| KG Connections | 779 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
PIK3CA["PIK3CA"]
PIK3CA -->|"causes"| ESCC["ESCC"]
PIK3CA -->|"activates"| MTOR["MTOR"]
PIK3CA -->|"activates"| mTOR["mTOR"]
PIK3CA -->|"target for"| Heart_Failure["Heart Failure"]
PIK3CA -->|"target for"| Ms["Ms"]
PIK3CA -->|"regulates"| Cancer["Cancer"]
PIK3CA -->|"inhibits"| Tumor["Tumor"]
PIK3CA -->|"target for"| Carcinoma["Carcinoma"]
PI3K["PI3K"] -->|"regulates"| PIK3CA
MDM2["MDM2"] -->|"regulates"| PIK3CA| Target | Relation | Type | Str |
|---|---|---|---|
| Cancer | therapeutic_target | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Tumor | associated_with | disease | 1.00 |
| Cancer | associated_with | disease | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| AKT | therapeutic_target | gene | 1.00 |
| Diffuse Intrinsic Pontine Glioma | associated_with | disease | 0.95 |
| AKT1 | activates | protein | 0.95 |
| AKT | upstream_of | protein | 0.95 |
| Pi3K/Akt/Mtor Pathway | involved_in | pathway | 0.95 |
| Pi3K-Akt-Mtor Pathway | activates | pathway | 0.95 |
| PI3K-Akt-mTOR Pathway | activates | pathway | 0.90 |
| PI3K | encodes | protein | 0.90 |
| Pi3K/Akt/Mtor Pathway | associated_with | pathway | 0.90 |
| ESCC | causes | disease | 0.90 |
| PI3K-AKT-mTOR signaling | participates_in | pathway | 0.90 |
| Pi3K/Akt | inhibits | pathway | 0.90 |
| Bladder Cancer Metabolism | regulates | phenotype | 0.85 |
| niche formation | activates | process | 0.85 |
| Tumor | inhibits | disease | 0.85 |
| Als | associated_with | disease | 0.85 |
| Aging | therapeutic_target | disease | 0.85 |
| Breast Cancer | therapeutic_target | disease | 0.85 |
| Cancer | inhibits | disease | 0.85 |
| PI3K/AKT/mTOR | activates | pathway | 0.85 |
| HIF1A | activates | gene | 0.82 |
| Chrysotoxine | interacts_with | compound | 0.80 |
| cell proliferation | promotes | process | 0.80 |
| Breast cancer | causes | disease | 0.80 |
| Vascular Niche Formation | involved_in | process | 0.80 |
| MAPK signaling | participates_in | pathway | 0.80 |
| MTOR | activates | protein | 0.80 |
| AKT | inhibits | gene | 0.80 |
| Pi3K/Akt | therapeutic_target | pathway | 0.80 |
| Trastuzumab Deruxtecan | associated_with | drug | 0.75 |
| Cancer | regulates | disease | 0.75 |
| Carcinoma | therapeutic_target | disease | 0.75 |
| Cancer | interacts_with | disease | 0.75 |
| Inflammation | therapeutic_target | disease | 0.75 |
| Als | inhibits | disease | 0.75 |
| Colorectal Cancer | inhibits | disease | 0.75 |
| Breast Cancer | inhibits | disease | 0.75 |
| AKT | interacts_with | gene | 0.70 |
| MTOR | therapeutic_target | gene | 0.70 |
| PIK3R1 | therapeutic_target | gene | 0.70 |
| AKT | contributes_to | gene | 0.70 |
| MTOR | contributes_to | gene | 0.70 |
| mTOR | activates | protein | 0.70 |
| Mtor | therapeutic_target | pathway | 0.70 |
| Mapk | therapeutic_target | pathway | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PI3K | inhibits | gene | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| Alpelisib | inhibits | drug | 0.95 |
| Paxalisib | inhibits | drug | 0.90 |
| PI3K | therapeutic_target | gene | 0.90 |
| CANCER | associated_with | gene | 0.90 |
| KRAS | associated_with | gene | 0.90 |
| Apitolisib | inhibits | drug | 0.85 |
| RLN | phosphorylates | protein | 0.85 |
| P2Ry12 | activates | protein | 0.85 |
| Chrysotoxine | targets | compound | 0.80 |
| PTEN | therapeutic_target | gene | 0.80 |
| CANCER | inhibits | gene | 0.80 |
| ARID1A | associated_with | gene | 0.70 |
| PTEN | associated_with | gene | 0.70 |
| CLCN8 | associated_with | gene | 0.70 |
| JAK2 | therapeutic_target | gene | 0.70 |
| TP53 | therapeutic_target | gene | 0.70 |
| PI3K | activates | gene | 0.70 |
| PI3K | contributes_to | gene | 0.70 |
| EGFR | therapeutic_target | gene | 0.70 |
| IGF1R | interacts_with | gene | 0.70 |
| TP53 | associated_with | gene | 0.70 |
| APC | associated_with | gene | 0.70 |
| PTEN | inhibits | gene | 0.70 |
| MAPK1 | targets | gene | 0.70 |
| MAPK1 | associated_with | gene | 0.70 |
| PI3K | treats | gene | 0.70 |
| GENES | associated_with | gene | 0.70 |
| APOPTOSIS | therapeutic_target | gene | 0.70 |
| OXIDATIVE STRESS | therapeutic_target | gene | 0.70 |
| MTOR PATHWAY | regulates | pathway | 0.65 |
| CDK4 | associated_with | gene | 0.60 |
| CASP3 | associated_with | gene | 0.60 |
| PI3K | regulates | gene | 0.60 |
| ESR1 | associated_with | gene | 0.60 |
| CHEK1 | associated_with | gene | 0.60 |
| MTOR | associated_with | gene | 0.60 |
| MDM2 | regulates | gene | 0.60 |
| STAT3 | therapeutic_target | gene | 0.60 |
| VEGFA | therapeutic_target | gene | 0.60 |
| MTOR | inhibits | gene | 0.60 |
| TNF | therapeutic_target | gene | 0.60 |
| BRCA1 | therapeutic_target | gene | 0.60 |
| PALB2 | therapeutic_target | gene | 0.60 |
| EGFR | activates | gene | 0.60 |
| AKT | inhibits | gene | 0.60 |
| HRAS | therapeutic_target | gene | 0.60 |
| MAPK3 | therapeutic_target | gene | 0.60 |
| MAPK1 | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||